Valuation: Rani Therapeutics Holdings, Inc.

Market Cap 77.06M 67.37M 61.91M 57.71M 109M 7.34B 111M 743M 289M 3.61B 289M 283M 12.43B P/E 2026 *
-3.99x
P/E 2027 * -3.51x
Enterprise Value 77.06M 67.37M 61.91M 57.71M 109M 7.34B 111M 743M 289M 3.61B 289M 283M 12.43B EV / Sales 2026 *
18.7x
EV / Sales 2027 * 15.6x
Free-Float
78.3%
Yield 2026 *
-
Yield 2027 * -
1 day+0.38%
1 week+4.81%
Current month+1.43%
1 month-11.86%
3 months-8.16%
6 months-43.29%
Current year-42.87%
1 week 0.73
Extreme 0.731
0.82
1 month 0.72
Extreme 0.72
0.9
Current year 0.68
Extreme 0.68
1.54
1 year 0.39
Extreme 0.387
3.87
3 years 0.39
Extreme 0.387
8.75
5 years 0.39
Extreme 0.387
36.27
10 years 0.39
Extreme 0.387
36.27
Manager TitleAgeSince
Chief Executive Officer 45 01/06/2021
Director of Finance/CFO 46 29/06/2026
Chief Tech/Sci/R&D Officer 42 01/01/2022
Director TitleAgeSince
Chairman 69 01/06/2021
Director/Board Member 80 01/09/2018
Director/Board Member 69 06/04/2021
Date Insider Type Main position Quantity % Market Cap.
06-03Free

Founder

3,800,000 3.8106%
06-03Free

Executive/Senior Manager

805,500 0.8077%
06-03Free

Chief Technology Officer

805,500 0.8077%
Change 5-day change 1-year change 3-year change Capi.($)
+0.38%+4.81%+44.06%-80.91% 77.06M
+0.68%+5.92%+80.45%+137.78% 58.73B
+2.32%+5.03%+75.51%+94.88% 53.92B
+3.86%+6.93%-11.32%-9.53% 24.67B
+4.30%+7.95%+14.11%+437.83% 24.19B
+4.74%+13.68%+45.58%-1.42% 18.8B
-0.29%+9.78%+44.62%-27.94% 17.61B
0.00%+20.78%+178.93%+360.74% 16.25B
+3.50%+1.97%+21.02%+191.95% 14.04B
+6.72%+19.38%+42.82% - 13.9B
Average +2.62%+6.84%+53.58%+122.60% 24.22B
Weighted average by Cap. +2.44%+5.53%+59.06%+138.41%

Financials

2026 *2027 *
Net sales 4.13M 3.61M 3.32M 3.09M 5.86M 393M 5.95M 39.81M 15.48M 193M 15.49M 15.16M 666M 4.92M 4.31M 3.96M 3.69M 7M 469M 7.1M 47.5M 18.47M 231M 18.49M 18.09M 794M
Net income -33.21M -29.04M -26.68M -24.87M -47.18M -3.16B -47.89M -320M -125M -1.55B -125M -122M -5.36B -39.93M -34.91M -32.08M -29.9M -56.71M -3.8B -57.57M -385M -150M -1.87B -150M -147M -6.44B
Net Debt - -
Logo Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. The Company has developed the RaniPill capsule, which is a proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. The RaniPill capsule is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. It has two configurations of the platform: the RaniPill GO and the RaniPill HC. The RaniPill GO is designed to deliver up to a 3 mg dose of drug in microtablet form with high bioavailability. It is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC. Its product candidate pipeline includes obesity programs (RT-114 and RT-116), immunology programs (RT-105 and RT-111) and endocrinology programs (RT-102 and RT-110).
Employees
70
Date Price Change Volume
02/07/26 $0.7713 +0.38% 504,534
01/07/26 $0.7684 +1.05% 473,116
30/06/26 $0.7604 -0.56% 213,003
29/06/26 $0.7647 +3.91% 545,525
26/06/26 $0.7359 -0.86% 830,349
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.7713USD
Average target price
7.500USD
Spread / Average Target
+872.38%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RANI Stock